Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper

Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper

Abstract Background Recent years show an exponential increased interest (“renaissance”) in the use of psychedelics for the treatment of mental disorders and broader. Some of these treatments, such as psilocybin for depression, are in the process of formal regulation by regulatory bodies in the US...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Destoop, P. Mohr, F. Butlen, P. Kéri, J. Samochowiec, L. De Picker, A. Fiorillo, K.P.C. Kuypers, G. Dom
Format: Article
Language:English
Published: Cambridge University Press 2025-01-01
Series:European Psychiatry
Subjects:
DMT
LSD
mental health
methodological challenges
psilocybin
Psychedelics
psychiatric disorders
Online Access:https://www.cambridge.org/core/product/identifier/S0924933824018066/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items